Loading clinical trials...
Loading clinical trials...
Does Targeting the Sural Nerve in Addition to the Posterior Tibial Nerve Increase the Effectiveness of Pulsed Radiofrequency Treatment in Chronic Plantar Heel Pain?
This observational study aims to compare the effectiveness of pulsed radiofrequency (PRF) treatment applied to the posterior tibial nerve alone versus PRF applied to both the posterior tibial and sural nerves in patients with chronic plantar heel pain. Outcomes will be assessed using the Visual Analog Scale (VAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score at baseline, 1 month, and 3 months after treatment.
Chronic plantar heel pain is a common condition frequently managed with interventional pain procedures. In routine clinical practice, pulsed radiofrequency (PRF) is commonly applied to the posterior tibial nerve under ultrasound guidance. In selected patients, PRF is additionally applied to the sural nerve based on clinical judgment. This observational study includes patients who have already undergone PRF treatment as part of standard care in the Algology Clinic. Patients will not be randomized, and no modification to treatment plans will be made for study purposes. Patients will be divided into two groups: those who received PRF to the posterior tibial nerve alone, and those who received PRF to both the posterior tibial and sural nerves. Pain intensity and functional outcomes will be retrospectively evaluated and compared between groups.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Ayse Betul Acar
Ankara, Turkey (Türkiye)
Start Date
June 1, 2025
Primary Completion Date
May 1, 2026
Completion Date
September 1, 2026
Last Updated
February 25, 2026
48
ESTIMATED participants
Pulsed radiofrequency
PROCEDURE
Lead Sponsor
Diskapi Teaching and Research Hospital
NCT07294196
NCT06284993
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06754982